A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy and safety of a range of oral
doses of OBE2109 versus placebo, in reducing endometriosis associated pain.